IDA blend vs Saudi Arabia: Antiretroviral therapy coverage
IDA blend
81.2%
in 2024
Saudi Arabia
93.0%
in 2024
IDA blend rank
13th
Saudi Arabia rank
11th
Antiretroviral therapy coverage over time
- IDA blend
- Saudi Arabia
How they compare
Saudi Arabia currently reports 93.0% against 81.2% in IDA blend, a difference of 11.8%.
That makes Saudi Arabia's figure about 1.1 times IDA blend's.
Across all 25 years both countries report, Saudi Arabia has been ahead every year.
IDA blend ranks 13th and Saudi Arabia ranks 11th of 23 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.3% | 26.1% | 20.8% | Saudi Arabia |
| 2010s | 45.0% | 57.9% | 12.9% | Saudi Arabia |
| 2020s | 75.2% | 90.0% | 14.8% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, IDA blend or Saudi Arabia?
- Saudi Arabia, at 93.0% against 81.2% in IDA blend as of 2024.
- What is the difference in antiretroviral therapy coverage between IDA blend and Saudi Arabia?
- 11.8%, with Saudi Arabia ahead.
- How many years of comparable data are there for IDA blend and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA blend and Saudi Arabia rank globally for antiretroviral therapy coverage?
- IDA blend ranks 13th and Saudi Arabia ranks 11th of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.